06887 SUNSHINE PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 0.77X | Oper Margin | 13.9% |
|---|---|---|---|
| LT Debt/Equity | 33.0% | Net Margin | 5.7% |
| Total Debt/Equity | 107.7% | Return on Equity | 6.3% |
| Price/Book | 5.23X | Return on Assets | 2.3% |
| (HKD 43.860) | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
| Net Profit (MHKD) | 303.26 | -220.61 | 203.82 | -1,355.76 |
|---|---|---|---|---|
| Net Profit Growth (%) | +237.5 | -208.2 | +115.0 | N/A |
| Earnings Per Share (HKD) | 0.622 | -0.5 | 0.486 | -4.112 |
| Earnings Per Share Growth (%) | +224.2 | -202.9 | +111.8 | N/A |
| Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend |
| P/E* (X) | 70.57 | N/A | 90.21 | N/A |
| Yield (%) | N/A | N/A | N/A | N/A |
| Dividend Share (%) | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 8.393 | N/A | N/A | N/A |
| Auditors' Opinion | N/A | N/A | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 4,815 | 4,019 | +19.8 | 6,386 |
| Operating Result | 439.515 | 122.619 | +258.4 | 1,389 |
| Associates | 0.049 | 0.293 | -83.3 | -0.029 |
| Profit Before Taxation | 439.564 | 141.054 | +211.6 | 1,385 |
| Taxation | 169.53 | 116.251 | +45.8 | 371.584 |
| Profit /( Loss) After Taxation | 270.034 | 24.803 | +988.7 | 1,014 |
| Minority Interests | -2.408 | 232.237 | -101.0 | 828.954 |
| Net Profit | 272.442 | -207.434 | -231.3 | 184.924 |
| Earnings Per Share () | 0.6215 | -0.5003 | -224.2 | 0.4862 |
| Announcement Date | 2026-03-31 | 2025-06-29 | NA | 2025-06-29 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
